World Tuberculosis Day 2024 theme “Yes! We can end TB” can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease

• Delia Goletti,
• Seif Al-Abri,
• Giovanni Battista Migliori,
• Cecilia Lindestam Arlehamn,
• Pranabashis Haldar,
• Christopher Sundling,
• Christopher da Costa,
• Kin Wang To,
• Adrian R. Martineau,
• Eskild Petersen,
• Alimuddin Zumla,
• Shui Shan Lee

Affiliations

Delia Goletti

Translational Research Unit, Department of Epidemiology and Preclinical Research National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy; Corresponding author:

Seif Al-Abri

Royal Hospital, Ministry of Health, Muscat, Oman

Giovanni Battista Migliori

Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy

Cecilia Lindestam Arlehamn

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, USA

Pranabashis Haldar

NIHR Leicester Biomedical Research Centre, Department of Respiratory Sciences, University of Leicester, Leicester, UK

Christopher Sundling

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Medicine and Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

Christopher da Costa

Coalition for Epidemic Preparedness Innovations, Washington, USA

Kin Wang To

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; S.H. Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China

Adrian R. Martineau

Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK

Eskild Petersen

Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark and ESCMID Emerging Infections Task Force, Basel, Switzerland

Alimuddin Zumla

Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, and NHIR-BRC, UCL Hospitals NHS Foundation Trust, London, United Kingdom

Shui Shan Lee

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China